This is a snippet of the transcript, sign up to read more.
All these vehicles were launched around Covid. People had savings, and these vehicles were selling above MSRP. For example, the SF90 in 2021. We were selling the SF90 Stradale about $200,000 above sticker. The client could use the car for one year, bring it back, and we would pay sticker and then sell it back easily for $200,000 over it. When the public found out about this, they started placing orders. Some people had the money to buy the car but not to keep it. There was a lot of speculation. Once the market changed and these cars started having many electrical issues, people started putting them up for sale. The market was flooded with SF90 Stradales. Then it followed with the SF90 Spider. Now the market is flooded with these vehicles from people who took delivery but were trying to make money on the car.
This is a snippet of the transcript, sign up to read more.
There were many speculators trying to make money. They saw the market went down, and now they're scared and trying to sell everything, so the price goes down. But once these vehicles get to the right hands, people who can actually keep and maintain them, the market will go back up. There's no replacement for the car. It's a Ferrari. It's still a Ferrari. It's 1,000 hp. That's a supercar from Ferrari. It has to go back up. In 2020, we had 10 new 812 Superfasts that people never took delivery of. We had to discount those cars from MSRP, even close to invoice, to be able to sell them as new vehicles.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.